Benznidazole Tablet
Product Images NDC 0642-7463

9 FDA label images from Exeltis Usa, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Benznidazole (NDC 0642-7463). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exeltis Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

Structural Formula (Image 01)
Chemical structure diagram of benznidazole, the active ingredient in Benznidazole tablets. The diagram shows the molecular arrangement including a benzene ring and nitroimidazole ring characteristic of benznidazole.*
FDA Label Image

Exeltis Logo (Image 02)

FDA Label Image

100 mg Treatment (Image 03)

100 mg Treatment (Image 03)
Illustrations of a Benznidazole tablet showing a full top view with a cross-shaped score and the letter 'E' embossed in each quadrant, a full side view showing the tablet's thickness and scored edge, and a side view held between thumb and index finger to indicate size. The tablet is round and scored for splitting.*
FDA Label Image

Figures 1 (3)

Figures 1 (3)
An instructional diagram showing three steps involving a tablet. Figure 1 depicts a person holding a tablet using thumb and forefinger. Figure 2 shows the tablet being broken in half by applying pressure with both hands. Figure 3 displays the tablet separated into two pieces, held between thumb and forefinger.*
FDA Label Image

75 mg Treatment (Image 05)

75 mg Treatment (Image 05)
Illustration showing the top view of a tablet divided into one-half and one-quarter sections, labeled with the letter 'E'. This diagram helps visualize tablet splitting for dosage adjustments.*
FDA Label Image

50 mg Treatment (Image 06)

50 mg Treatment (Image 06)
Illustrations showing a benznidazole tablet in half, including top and side views, and being held between thumb and index finger for size context. The half-tablet features the letter 'E' engraved on each half surface.*
FDA Label Image

25 mg Treatment (Image 07)

25 mg Treatment (Image 07)
Illustrations showing one-fourth of a benznidazole 100 mg tablet from different angles: top view with an embossed 'E', side view displaying the tablet's thickness, and side view held between thumb and index finger to indicate size.*
FDA Label Image

Principal Display Panel (100 mg Carton)

Principal Display Panel (100 mg Carton)
The packaging label for Benznidazole tablets, 100 mg oral tablets. The label includes dosage strength, quantity of 100 tablets, manufacturer information (Chemo Research, Laboratorios Liconsa), and distributor details (Exeltis USA, Inc.). Storage instructions and a note to see prescribing information for dosage and administration are also visible. The design features blue and grey tones with the Exeltis logo at the bottom.*
FDA Label Image

Principal Display Panel (12.5 mg Carton)

Principal Display Panel (12.5 mg Carton)
Box label for Benznidazole tablets 12.5 mg, oral dosage form, containing 100 tablets. Manufactured for Chemo Research, S.L. in Spain and distributed by Exeltis USA, Inc. The label includes storage instructions and a reminder to see prescribing information for dosage and administration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.